SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
LFWD

Lifeward Ltd. (NASDAQ:LFWD)

Israel · Delayed Price · Currency is USD
Healthcare · Medical Devices
$2.80-$0.16 (-5.30%)
 
Market cap
$7.96M
Insider Score
Analyst consensus
Market Cap$7.96M-55.1%
Revenue (ttm)$21.05M
Net Income-$32.71M
EPS-$13.15
Shares Out2.84M
PE Ration/a
Forward PE-1.95
Dividendn/a
Ex-Dividend Daten/a
Volume35,411
Open$2.80
Previous Close$2.96
Day's Range$2.73 - $2.98
52-Week Range$2.67 - $9.61
Beta0.56
AnalystsStrong Buy
Price Target$8.50(+203.25%)
Earnings DateNov 13, 2026
-5.41% (1D)
No price history available.

About LFWD

Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal cord injury; ReStore Exo-Suit, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals' post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024. Lifeward Ltd. was incorporated in 2001 and is based in Yokneam Illit, Israel.

Address
3 Hatnufa St., Yokneam Illit, 2069203, Israel
Market Cap
8 million
Employees
81
Industrial Classification
Medical Devices
1 Day
-4.98%
5 Days
-30.96%
1 Month
-51.81%
6 Months
-60.24%
1 Year
-55.08%

$LFWD stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in LFWD holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by LFWD's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

LFWD Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New LFWD patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to LFWD from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from LFWD’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
No data yet
—
Analyst Ratings
62% of score
99
News & Sentiment
38% of score
35

News check: Q3 earnings miss on revenue with reported loss indicates disappointing financial performance for the quarter.

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.